Publications by authors named "Juan-David Assaf"

Claim this Profile
O
Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer.
Patricia Iranzo, Ana Callejo, Juan David Assaf, Gaspar Molina, Daniel Esteban Lopez

Front Med (Lausanne)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort.
Susana Cedres, Juan-David Assaf, Patricia Iranzo, Ana Callejo, Nuria Pardo

Sci Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interrelations between Patients' Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients.
Ana Callejo, Joan Frigola, Patricia Iranzo, Caterina Carbonell, Nely Diaz, Juan David Assaf

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neratinib plus capecitabine for the treatment of advanced HER2-positive breast cancer.
Mafalda Oliveira, Laia Garrigós, Juan David Assaf, Santiago Escrivá-de-Romaní, Cristina Saura

Expert Rev Anticancer Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis